Product Information

BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.2233 per EA under NDC 68462088030. Its NADAC has been published 247 times since Feb 23, 2022.

FDA first approved this application on Jan 26, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB

Bisoprolol Fumarate and Hydrochlorothiazide
$0.2233per EA

Strength

10; 6.25 mg/1; mg/1

NDC

68462088030

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA215995

FDA Approved

1/26/2022

TE Code

AB

On Market Since

1/26/2022

Pharmacological Classes

Adrenergic beta-Antagonists
Increased Diuresis
Thiazide Diuretic
Thiazides
beta-Adrenergic Blocker

Price Statistics

The NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB has been published 247 times since Feb 23, 2022, and over the history we have for it it has declined 29.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2233 per EA
All-time high$0.3489 (Nov 16, 2022)
All-time low$0.1227 (Nov 20, 2024)
52-week high$0.2242
52-week low$0.2006
Median price$0.2409
Average price$0.2482
Largest weekly change+49.9% (Dec 18, 2024)
Weeks tracked247
Tracking sinceFeb 23, 2022

Price History

1W

0.0%

1M

+6.7%

3M

+11.3%

6M

+3.0%

1Y

+8.3%

3Y

-9.9%

5Y

N/A

All

-29.0%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.2233 per EA (NDC 68462088030), effective Nov 11, 2026.

How has the price of BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB changed over time?

Over the history we have for it, the NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB has declined 29.0%. It has been tracked across 247 weekly CMS publications since Feb 23, 2022.

What are the highest and lowest recorded NADAC prices for BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB?

Since Feb 23, 2022, the NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB has ranged from a low of $0.1227 (Nov 20, 2024) to a high of $0.3489 (Nov 16, 2022), with a median of $0.2409 per EA.

Are there cheaper alternatives to BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB, is $0.2207 per EA — about 1% below BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB.

Who manufactures BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB?

BISOPROLOL-HYDROCHLOROTHIAZIDE 10-6.25 MG TAB (NDC 68462088030) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.